Search

Your search keyword '"McCorrister, Stuart"' showing total 44 results

Search Constraints

Start Over You searched for: Author "McCorrister, Stuart" Remove constraint Author: "McCorrister, Stuart" Language english Remove constraint Language: english
44 results on '"McCorrister, Stuart"'

Search Results

2. Increased genital mucosal cytokines in Canadian women associate with higher antigen-presenting cells, inflammatory metabolites, epithelial barrier disruption, and the depletion of L. crispatus

6. Human Papillomavirus 16 E6 and E7 Oncoproteins Alter the Abundance of Proteins Associated with DNA Damage Response, Immune Signaling and Epidermal Differentiation.

7. A functional phenylacetic acid catabolic pathway is required for full pathogenicity of Burkholderia cenocepacia in the Caenorhabditis elegans host model

8. Vaginal microbiome-hormonal contraceptive interactions associate with the mucosal proteome and HIV acquisition.

10. Pregnancy associates with alterations to the host and microbial proteome in vaginal mucosa.

11. Comparison of genomes and proteomes of four whole genome-sequenced Campylobacter jejuni from different phylogenetic backgrounds.

12. Microbiome Composition and Function Drives Wound-Healing Impairment in the Female Genital Tract.

14. Increased levels of inflammatory cytokines in the female reproductive tract are associated with altered expression of proteases, mucosal barrier proteins, and an influx of HIV-susceptible target cells.

17. Fit-for-purpose curated database application in mass spectrometry-based targeted protein identification and validation.

18. DNA Sequence Heterogeneity of Campylobacter jejuni CJIE4 Prophages and Expression of Prophage Genes.

19. The CJIE1 prophage of Campylobacter jejuni affects protein expression in growth media with and without bile salts.

20. Proteomic Analysis of a NAP1 Clostridium difficile Clinical Isolate Resistant to Metronidazole.

22. Unbiased Proteomics Analysis Demonstrates Significant Variability in Mucosal Immune Factor Expression Depending on the Site and Method of Collection.

23. A simple shotgun proteomics method for rapid bacterial identification.

24. MS-H: A Novel Proteomic Approach to Isolate and Type the E. coli H Antigen Using Membrane Filtration and Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).

25. Effect of gamma radiation on the identification of bacterial pathogens by MALDI-TOF MS

27. Mx2 Expression Is Associated with Reduced Susceptibility to HIV Infection in Highly Exposed HIV Seronegative Sex Workers from Nairobi, Kenya.

28. Molecular Signatures of Immune Activation and Epithelial Barrier Remodeling Are Enhanced during the Luteal Phase of the Menstrual Cycle: Implications for HIV Susceptibility.

29. Evaluation of MALDI-TOF mass spectroscopy methods for determination of Escherichia coli pathotypes.

30. A Systems Biology Examination of the Human Female Genital Tract Shows Compartmentalization of Immune Factor Expression.

31. Detection of Antimicrobial Resistance Using Proteomics and the Comprehensive Antibiotic Resistance Database: A Case Study.

32. Plasmid Negative Regulation of CPAF Expression Is Pgp4 Independent and Restricted to Invasive Chlamydia trachomatis Biovars.

33. Chlamydial Protease-Like Activity Factor and Type III Secreted Effectors Cooperate in Inhibition of p65 Nuclear Translocation.

34. Phenotypic H-Antigen Typing by Mass Spectrometry Combined with Genetic Typing of H Antigens, O Antigens, and Toxins by Whole-Genome Sequencing Enhances Identification of Escherichia coli Isolates.

35. Highly Pathogenic H5N1 and Novel H7N9 Influenza A Viruses Induce More Profound Proteomic Host Responses than Seasonal and Pandemic H1N1 Strains.

36. Rapid, Sensitive, and Specific Escherichia coli H Antigen Typing by Matrix-Assisted Laser Desorption Ionization-Time of Flight-Based Peptide Mass Fingerprinting.

37. MALDI-TOF MS detection of carbapenemase activity in clinical isolates of Enterobacteriaceae spp., Pseudomonas aeruginosa, and Acinetobacter baumannii compared against the Carba-NP assay.

38. Quality evaluation of LC-MS/MS-based E. coli H antigen typing (MS-H) through label-free quantitative data analysis in a clinical sample setup.

39. Fit-for-purpose curated database application in mass spectrometry-based targeted protein identification and validation.

40. Sequence-level and dual-phase identification of Salmonella flagellum antigens by liquid chromatography-tandem mass spectrometry (LC-MS/MS).

41. Comparative study of traditional flagellum serotyping and liquid chromatography-tandem mass spectrometry-based flagellum typing with clinical Escherichia coli isolates.

42. DNA sequence heterogeneity of Campylobacter jejuni CJIE4 prophages and expression of prophage genes.

43. Proteomic analysis of a NAP1 Clostridium difficile clinical isolate resistant to metronidazole.

44. MS-H: a novel proteomic approach to isolate and type the E. coli H antigen using membrane filtration and liquid chromatography-tandem mass spectrometry (LC-MS/MS).

Catalog

Books, media, physical & digital resources